The Institute would like to highlight the appointment of Anne-Marie Mes-Masson, to the prestigious Canada’s Most Powerful Women: Top 100 circle, in the Science and Technology category. One more reason to be proud? She was the Scientific Director of the Institute from 2003 to 2018!
A pioneer in the field of the creation of biobanks, her research over the past three decades has mainly focused on ovarian, breast and prostate cancers. She has established a translational research program focused on the development of personalized medicine in oncology and her fundamental research is focused on the prediction of therapeutic responses and on the development of new therapeutic agents for ovarian cancer and breast.
It is a fully deserved award for a researcher who shines through her excellence and her commitment to cancer research.
Pfizer Canada offers $100,000 grant for research
6 February 2023
The Institute is pleased to announce that Pfizer Canada is supporting a digestive oncology fellowship program with a generous grant […]
Personalized cellular immunotherapy: Dr. Simon Turcotte, one of the three principal scientists of a pan-Canadian project
21 April 2023
Spotlight on Dr. Simon Turcotte, Research Fellow of the Institute and one of the 3 scientists from the Pan-Canadian Project, […]